Delivery Order SPE2DB24D2205-SPE2DB25FEAUC

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, with ID SPE2DB24D2205 and SPE2DB25FEAHZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,853.52 Firm Fixed Price Delivery Order contract is for the supply of VISCOAT SYRINGE 0.5ML, a medical product. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBDT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,853.52 firm fixed-price delivery order is for the supply of 0.5mL VISCOAT syringes, with an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.80 firm fixed price contract is for the delivery of VISCOAT SYRINGE 0.5ML products, with a completion date of February 18, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $4,666.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISCOAT SYRINGE 0.5ML, a medical supply item. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on January 8, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite...
This federal contract award, valued at $5,796.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "VISCOAT SYRINGE 0.5ML" medical supplies, with a completion date of March 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEAQQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,018.16, is for the delivery of 0.5ML VISCOAT syringes, classified as a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $4,853.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5mL VISCOAT syringes, a medical supply item, with a completion date of March 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. In addition to this specific contract award,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,723.20 firm fixed price delivery order is for the supply of VISCOAT SYRINGE 0.5ML, a medical product. The contract has an ultimate completion date of September 21, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order worth $3,126.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567684004 ! VISCOAT SYRINGE 0.75ML, with a completion date of March 26, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,666.80 fixed-price delivery order is for the supply of 0.5ML VISCOAT SYRINGES, with a completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEAUC
    Delivery Order

This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEAUC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,853.52 firm fixed-price delivery order is for the supply of 4,567,870,660 units of the VISCOAT SYRINGE 0.5ML medical product. The contract has an ultimate completion date of April 11, 2025 and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:10 PM